PCSK9 Forum
Click here to invite colleagues
to join the Forum for FREE
Facebook Twitter RSS YouTube linkedin
Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact
4th Meeting of the PCSK9 Forum Editorial Board
Is PCSK9 therapy the solution to all cardiovascular disease?

In this editorial
Prof. Anthony S. Wierzbicki, Guy’s & St Thomas’ Hospitals, London, UK discusses his view of the evidence and what we still need to know about these novel treatments.

Read more »

Focus on FH 
First data from UK Paediatric Register for Familial Hypercholesterolaemia
Cholesterol testing and family history drive diagnosis in children according to Prof. Gerald Watts, University of Western Australia, Perth, Australia.

Read more »
Why PCSK9 inhibitors are needed in FH
Spanish SAFEHEART Registry shows the extent of poor LDL-cholesterol control despite high-intensity statin plus ezetimibe according to Prof. Derick Raal, University of the Witwatersrand, Johannesburg, South Africa.

Read more »
New electronic tool for FH screening shows promise
An advance for FH screening in primary care.

Read more »
News on the Congress Front
84th Congress of the European Atherosclerosis Society, May 29 - June 1, Innsbruck Austria.
PCSK9 Forum will be reporting with news and views from the experts.

Check back on www.pcsk9forum.org »
New and updated edition of our popular therapeutic guide

New eBookA second edition of the free introductory guide: PCSK9 Inhibition - New Therapies in Cardiovascular Risk Reduction is now available on the Forum’s website. This very popular book has been updated with the latest information discussing the biology and therapeutic potential of PCSK9 inhibition.

As you know, this downloadable e-book is freely available to all registered members of the Forum.

Read online » Download now »

Forward to colleagues »
Click here to invite colleagues to join FREE
Questions & Answers
Why are new treatments needed?
Inhibition of PCSK9 offers the real possibility of improved management of high-risk patients.

Read the full answer and other questions on the PCSK9 Forum »
Like us on Facebook
For the latest updates, PCSK9 news and analysis.
Follow us on Twitter
Hot topics, news and conference reports.
YouTube Channel
For videos, interviews and webcasts from leading experts.
Educational Partners
and Supporters
Amgen Lilly The Medicines Company pFizer Sanofi
Copyright PCSK9 Forum 2016. Please click here to unsubscribe from future mailings.